(Q42712946)

5 November 2017

Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway (English)

1 reference

5 November 2017

1 reference

1 reference

Farhad Ghadiri Soufi

1

1 reference

PubMed ID

23406761

5 November 2017

Daryoush Mohammad-Nejad

series ordinal

2

1 reference

PubMed ID

23406761

5 November 2017

Hamid Ahmadieh

series ordinal

3

1 reference

5 November 2017

1 January 2012

1 reference

5 November 2017

10

1 reference

inferred from page(s)

published in

Pharmacological Reports

1 reference

5 November 2017

64

1 reference

5 November 2017

6

1 reference

5 November 2017

1505-1514

1 reference

Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits

5 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol bioavailability and toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Glycemic response and health: summary of a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Endoplasmic reticulum stress-related factors protect against diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Oxidative stress and diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Diabetes, oxidative stress, and antioxidants: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Oxidative stress in a model of experimental diabetic retinopathy: the utility of peroxinytrite scavengers

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

The change of oxidative stress products in diabetes mellitus and diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Oxidative stress, insulin signaling, and diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol, obesity and diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970948-9

7 January 2021

10.1016/S1734-1140(12)70948-9

Identifiers

DOI

1 reference

5 November 2017

1 reference

PubMed ID

23406761